Compliance, Validation and Quality for Pharmaceutical Equipment

A machine is only useful in a GMP plant if it can be qualified, cleaned, controlled and audited. This section explains what regulators expect from equipment, which documents suppliers must provide, and how to test machines before they reach production.

20 guides · By the Hello Pharma Editorial Team · Last updated 19 November 2026

Compliance is easiest to build in at purchase. Materials of construction, surface finish, cleanability, control system validation and audit trails are all fixed by design; fixing them after installation is expensive and slow. The best time to ask the right questions is before the purchase order is signed.

The guides below cover the qualification life cycle, factory and site acceptance testing, electronic records under 21 CFR Part 11 and EU Annex 11, data integrity in PLC and SCADA systems, GAMP 5 software categories, EU GMP and WHO-GMP equipment expectations, India's revised Schedule M, ATEX zones, containment bands and the machine features that help avoid inspection findings.

All 20 guides in this section

Guides marked coming soon are being published in batches; this page links to each one as it goes live.

Find suppliers

Companies in the Hello Pharma supplier directory that match this section.

Frequently asked questions

What are DQ, IQ, OQ and PQ?

Design qualification (DQ) confirms the proposed design meets the user requirements. Installation qualification (IQ) verifies the machine is installed correctly with the right components and documents. Operational qualification (OQ) tests that it works across its operating ranges. Performance qualification (PQ) shows it performs consistently with real product or a suitable simulation under routine conditions.

What does 21 CFR Part 11 require from pharmaceutical equipment?

Part 11 is the US FDA rule for electronic records and electronic signatures. A machine that creates GMP records electronically needs validated software, unique user logins with role-based access, secure time-stamped audit trails that cannot be edited, controls on record changes, and electronic signatures linked to their records. EU GMP Annex 11 sets similar expectations in Europe.

What is India's revised Schedule M?

Revised Schedule M is India's updated good manufacturing practice standard, notified on 28 December 2023 and titled Good Manufacturing Practices and Requirements of Premises, Plant and Equipment for Pharmaceutical Products. It adds a pharmaceutical quality system, quality risk management, product quality review, and equipment qualification and validation. Larger manufacturers had to comply first; smaller firms that applied for an extension had until 31 December 2025, and the revised schedule has applied to every manufacturing unit since 1 January 2026.

Ready to read pharma differently?

Join the Hello Pharma community for editorial, intelligence and engineering reference from pharma manufacturing.